Vitruvian Shield SA

AI-native operating system for decentralized clinical trials

Vitruvian Shield is a Swiss AI-native SaaS platform for Decentralized Clinical Trials (DCT) and Remote Patient Monitoring (RPM). We unify CTMS, EDC, eConsent, ePRO, RPM and regulatory output generation in a single compliant environment, paired with our proprietary Thryve medical IoT devices. Our customers are pharma sponsors, CROs and hospitals running fragmented, expensive trials. Built on Microsoft Azure and aligned with EU MDR, FDA 21 CFR Part 11, ISO 13485, ISO 27001, GDPR, HIPAA and ICH E6(R3) GCP. Active studies include the ULS São João oncology pilot and the PT-EPI-DCT-002 epilepsy DCT. We are closing a CHF 2 to 4M Series A to scale across Europe and the Gulf and become the infrastructure layer of the global DCT market projected at USD 14B by 2030.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

No news

No Jobs

Videos

What we offer to CROs and Hospitals

EConsent ecro esurvey in one place

VITRUVIAN SHIELD AN EXCLUSIVE EHEALTH PAAS FOR MEDICAL RESEARCH, REMOTE PATIENT MONITORING

?? Introducing Vitruvian Shield’s AI-Powered Assistant & Smart Event Reporting

Vitruvian Shield an innovating eHealth CTMS & RPM PaaS for decentralized and hybrid clinical trials

Reportage RTS

No Awards

Vitruvian Shield SA

AI-native operating system for decentralized clinical trials

Headquarter:
Epalinges

Foundation Date:
February 2016

Technology:

  • Medtech

Sectors:

  • Big Data
  • Digital Health
  • Diagnostics
  • Drug development platforms
  • Machine Learning / AI
  • Medical devices
  • Medtech
  • SaaS
  • Patient monitoring
  • Wearable technologies